AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.
In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.
Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.
www.facesofdigitalhealth.com
https://fodh.substack.com/
Show notes:
[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression
[00:04:00] Biotech in Switzerland
[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.
[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.
[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.
[00:12:00] Challenges in Colorectal Cancer Screening
[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development
[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests
[00:18:00] The Future of Liquid Biopsy and Precision Medicine
[00:20:00] Real-world Application and Impact of Novel Biomarkers
[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland
[00:24:00] Partnerships and Collaborations to Accelerate Adoption
Why Aren't Polypills Used and What Are The Limits Of Pharmacogenomics? (John Horn)
Why Do Doctors Skip Medication Interaction Alerts? (David W. Bates)
How Do Nurses See Medication Administration Challenges? (Martina Viduka)
How Demanding Is Management of Psychiatric Disorders? (Roni Shiloh)
F138 (OVER)DOSE Part 2 - after documentary expert panel discussion
F137 (OVER)DOSE Part 1 - documentary adapted for radio
F136 Do You Understand the Psychology of Chronic Disease? (David Kliff, The Diabetic Investor)
F135 Why is Medication Price Transparency in the US Complicated and Problematic? (Carm Huntress)
F134 What Do You Know About SPACs in Healthcare? (mHealth Israel episode)
F133 How Can You Make Cancer Care Children-Friendly? (Simone Mozzilli, Liliane Dubois, Beaba)
Trailer 1: (OVER)DOSE - How Can We Prevent Medication Errors?
F132 What's The State of Cybersecurity In Healthcare? (Lee Kim)
F131 How Can We Better Measure Pain? (Sara E. Berger, IBM)
F130 How Can We Optimize the Use of Antibiotics? (Oliver Schacht, OpGen)
F129 What Is the State of Digital Health Law? (Bianca Rose Phillips)
F128 What Are We Missing About AI Development In Healthcare? (Casey Ross)
F127 Why Do People Go Bankrupt Due to Medical Costs in the US? (Ric Sinclair)
F126 How is Tradition Hindering Health Literacy in Kenya, Tanzania and Malaysia? (Shamala Hinrichsen, Mariatheresa Samson Kaduschi)
F125 Amazon in Healthcare, AI Related Disparities and the Microbiome Challenges (Erin Brodwin)
F124 AgeTech 4/4: How would you choose to die? (Ryan Van Wert, Vynca)
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast